VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease. Krebs, R., Tikkanen, J. M., Ropponen, J. O., Jeltsch, M., Jokinen, J. J., Yla-Herttuala, S., Koskinen, P. K., Nykanen, A. I., & Lemstrom, K. B. Journal of Heart and Lung Transplantation, 30(4):S118–S118, March, 2011. undefined APR 2011 VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease WOS:000288924300340
VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease [link]Paper  abstract   bibtex   
Purpose: The role of VEGF-C/VEGFR-3 signaling in the development of obliterative airway disease (OAD) as a manifestation of chronic rejection was investigated in the rat tracheal allograft model. Methods and Materials: Tracheal allografts were transplanted heterotopically from DA- to WF-rats (syngeneic controls: DA-\textgreaterDA). Expression of VEGF-C and VEGFR-3 protein and lymphatic vessel marker LYVE-1 was analyzed from normal, syngeneic, and allogeneic tracheal transplants. Adenovirally mediated human VEGF-C (AdVEGF-C) and VEGFR-3 Ig (VEGF-C trap) gene transfer was used to overexpress VEGF-C and to suppress VEGF-C/VEGFR-3 signaling, respectively (controls: AdLacZ). Cyclosporine A (CsA) was used for background immunosuppression. Tracheal allografts were removed 10 and 30 days after transplantation for histology, immunohistochemistry, and real-time PCR analysis of cytokine expression. Results: Please, see figure for summary of results. Conclusions: Our results show that VEGF-C/VEGFR-3-signaling induces Th17-mediated alloimmune activation leading to increased OAD. Inhibition of VEGF-C/VEGFR-3-signaling attenuates allograft inflammation and OAD development, suggesting a possible site of intervention in the development of obliterative bronchiolitis after lung transplantation.
@article{krebs_vegf-cvegfr-3_2011,
	title = {{VEGF}-{C}/{VEGFR}-3 {Signaling} {Regulates} {Inflammatory} {Response} in {Development} of {Obliterative} {Airway} {Disease}},
	volume = {30},
	url = {http://dx.doi.org/10.1016/j.healun.2011.01.348},
	abstract = {Purpose: The role of VEGF-C/VEGFR-3 signaling in the development of obliterative airway disease (OAD) as a manifestation of chronic rejection was investigated in the rat tracheal allograft model. Methods and Materials: Tracheal allografts were transplanted heterotopically from DA- to WF-rats (syngeneic controls: DA-{\textgreater}DA). Expression of VEGF-C and VEGFR-3 protein and lymphatic vessel marker LYVE-1 was analyzed from normal, syngeneic, and allogeneic tracheal transplants. Adenovirally mediated human VEGF-C (AdVEGF-C) and VEGFR-3 Ig (VEGF-C trap) gene transfer was used to overexpress VEGF-C and to suppress VEGF-C/VEGFR-3 signaling, respectively (controls: AdLacZ). Cyclosporine A (CsA) was used for background immunosuppression. Tracheal allografts were removed 10 and 30 days after transplantation for histology, immunohistochemistry, and real-time PCR analysis of cytokine expression. Results: Please, see figure for summary of results.
Conclusions: Our results show that VEGF-C/VEGFR-3-signaling induces Th17-mediated alloimmune activation leading to increased OAD. Inhibition of VEGF-C/VEGFR-3-signaling attenuates allograft inflammation and OAD development, suggesting a possible site of intervention in the development of obliterative bronchiolitis after lung transplantation.},
	number = {4},
	journal = {Journal of Heart and Lung Transplantation},
	author = {Krebs, R. and Tikkanen, J. M. and Ropponen, J. O. and Jeltsch, M. and Jokinen, J. J. and Yla-Herttuala, S. and Koskinen, P. K. and Nykanen, A. I. and Lemstrom, K. B.},
	month = mar,
	year = {2011},
	note = {undefined
APR 2011
VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease
WOS:000288924300340},
	pages = {S118--S118},
}

Downloads: 0